{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:00:08Z","timestamp":1792166408759,"version":"4.4.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019791","name":"Istanbul Medipol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019791","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Stroke is a major cause of mortality and long-term disability worldwide. Patients with autoimmune rheumatic diseases (ARDs) exhibit a significantly increased risk of both ischemic and hemorrhagic strokes, particularly at younger age. Systemic inflammation, immune-mediated vascular injury, antiphospholipid antibodies, accelerated atherosclerosis, and comorbidities contribute to this elevated cerebrovascular burden. This review aims to comprehensively overview stroke epidemiology, pathophysiological mechanisms, clinical characteristics, prevention strategies, and post-stroke rehabilitation in patients with ARDs. Literature searches were conducted using Medline\/PubMed, Scopus, Web of Science, and the Directory of Open Access Journals (DOAJ) databases up to February 1, 2026. Studies evaluating stroke incidence, risk factors, mechanistic pathways, prevention approaches, and rehabilitation in rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, ankylosing spondyloarthritis, systemic vasculitides, and Beh\u00e7et disease were included. Stroke risk is markedly increased across ARDs, with relative risks ranging from 1.3 to 2.5, depending on disease subtype. Systemic lupus erythematosus and systemic vasculitides confer particularly high cerebrovascular risk, often presenting at younger age and associated with worse functional outcomes. Chronic systemic inflammation, endothelial dysfunction, autoantibody-mediated thrombosis, genetic susceptibility, and accelerated atherosclerosis represent central mechanistic pathways. Certain immunomodulatory therapies may mitigate stroke risk through inflammation control, whereas others require careful cardiovascular risk assessment. Post-stroke recovery may be adversely influenced by persistent inflammatory activity and musculoskeletal comorbidities, underscoring the importance of multidisciplinary management. Early risk stratification, tight control of systemic inflammation, individualized immunomodulatory therapy, and structured rehabilitation strategies are essential to improve cerebrovascular outcomes in ARDs. Future research should focus on personalized risk prediction models and targeted preventive interventions in this high-risk population.<\/jats:p>","DOI":"10.1007\/s00296-026-06110-7","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T01:05:18Z","timestamp":1775437518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Stroke in autoimmune rheumatic diseases"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1234-7044","authenticated-orcid":false,"given":"Saltanat K.","family":"Yerkebayeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0338-3281","authenticated-orcid":false,"given":"Meirgul I.","family":"Assylbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5042-1191","authenticated-orcid":false,"given":"Yuliya","family":"Fedorchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2754-1232","authenticated-orcid":false,"given":"Ahmet","family":"Usen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"2","key":"6110_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/17474930241308142","volume":"20","author":"VL Feigin","year":"2025","unstructured":"Feigin VL, Brainin M, Norrving B, Martins SO, Pandian J, Lindsay P, Grupper FM, Rautalin I (2025) World Stroke Organization: Global Stroke Fact Sheet 2025. Int J Stroke 20(2):132\u2013144. https:\/\/doi.org\/10.1177\/17474930241308142","journal-title":"Int J Stroke"},{"issue":"10","key":"6110_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","volume":"23","author":"GBD 2021 Stroke Risk Factor Collaborators","year":"2024","unstructured":"GBD 2021 Stroke Risk Factor Collaborators (2024) Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23(10):973\u20131003. https:\/\/doi.org\/10.1016\/S1474-4422(24)00369-7","journal-title":"Lancet Neurol"},{"issue":"1","key":"6110_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/17474930251362583","volume":"21","author":"A Nehme","year":"2026","unstructured":"Nehme A, Li L (2026) The rising incidence of stroke in the young: epidemiology, causes and global impact. Int J Stroke 21(1):14\u201323. https:\/\/doi.org\/10.1177\/17474930251362583","journal-title":"Int J Stroke"},{"issue":"4","key":"6110_CR4","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1161\/STROKEAHA.115.012052","volume":"47","author":"SJ Wiseman","year":"2016","unstructured":"Wiseman SJ, Ralston SH, Wardlaw JM (2016) Cerebrovascular disease in rheumatic diseases: a systematic review and meta-analysis. Stroke 47(4):943\u2013950. https:\/\/doi.org\/10.1161\/STROKEAHA.115.012052","journal-title":"Stroke"},{"issue":"1\u20132","key":"6110_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.09.009","volume":"277","author":"R Behrouz","year":"2014","unstructured":"Behrouz R (2014) The risk of ischemic stroke in major rheumatic disorders. J Neuroimmunol 277(1\u20132):1\u20135. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.09.009","journal-title":"J Neuroimmunol"},{"issue":"12","key":"6110_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11910-015-0600-y","volume":"15","author":"AM Zha","year":"2015","unstructured":"Zha AM, Di Napoli M, Behrouz R (2015) Prevention of stroke in rheumatoid arthritis. Curr Neurol Neurosci Rep 15(12):77 https:\/\/doi.org\/10.1007\/s11910-015-0600-y","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"6110_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.31138\/mjr.30.1.7","volume":"30","author":"D Nikolopoulos","year":"2019","unstructured":"Nikolopoulos D, Fanouriakis A, Boumpas DT (2019) Cerebrovascular events in systemic lupus erythematosus: diagnosis and management. Mediterr J Rheumatol 30(1):7\u201315. https:\/\/doi.org\/10.31138\/mjr.30.1.7","journal-title":"Mediterr J Rheumatol"},{"issue":"3","key":"6110_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248564","volume":"16","author":"W Liu","year":"2021","unstructured":"Liu W, Ma W, Liu H, Li C, Zhang Y, Liu J, Liang Y, Zhang S, Wu Z, Zang C, Guo J, Li L (2021) Stroke risk in arthritis: a systematic review and meta-analysis of cohort studies. PLoS ONE 16(3):e0248564. https:\/\/doi.org\/10.1371\/journal.pone.0248564","journal-title":"PLoS ONE"},{"issue":"15","key":"6110_CR9","doi-asserted-by":"publisher","first-page":"1272557","DOI":"10.3389\/fimmu.2024.1272557","volume":"9","author":"YC Huang","year":"2024","unstructured":"Huang YC, Lai EC, Liao TC, Weng MY (2024) Evaluating the risk of ischemic stroke at a young age in patients with autoimmune inflammatory rheumatic diseases: a population-based cohort study in Taiwan. Front Immunol 9(15):1272557. https:\/\/doi.org\/10.3389\/fimmu.2024.1272557","journal-title":"Front Immunol"},{"issue":"3","key":"6110_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1161\/STROKEAHA.119.024157","volume":"51","author":"NS Parikh","year":"2020","unstructured":"Parikh NS, Merkler AE, Iadecola C (2020) Inflammation, autoimmunity, infection, and stroke: epidemiology and lessons from therapeutic intervention. Stroke 51(3):711\u2013718. https:\/\/doi.org\/10.1161\/STROKEAHA.119.024157","journal-title":"Stroke"},{"key":"6110_CR11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"issue":"2","key":"6110_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001247","volume":"6","author":"J Yazdany","year":"2020","unstructured":"Yazdany J, Pooley N, Langham J, Nicholson L, Langham S, Embleton N, Wang X, Desta B, Barut V, Hammond E (2020) Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis. RMD Open 6(2):e001247. https:\/\/doi.org\/10.1136\/rmdopen-2020-001247","journal-title":"RMD Open"},{"issue":"3","key":"6110_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/09612033221147471","volume":"32","author":"N Bello","year":"2023","unstructured":"Bello N, Meyers KJ, Workman J, Hartley L, McMahon M (2023) Cardiovascular events and risk in patients with systemic lupus erythematosus: systematic literature review and meta-analysis. Lupus 32(3):325\u2013341. https:\/\/doi.org\/10.1177\/09612033221147471","journal-title":"Lupus"},{"issue":"1","key":"6110_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/svn-2022-001499","volume":"9","author":"JA Huang","year":"2024","unstructured":"Huang JA, Lin CH, Wu MJ, Chen YH, Chang KC, Hou CW (2024) Ten-year follow-up investigation of stroke risk in systemic lupus erythematosus. Stroke Vasc Neurol 9(1):1\u20137. https:\/\/doi.org\/10.1136\/svn-2022-001499","journal-title":"Stroke Vasc Neurol"},{"issue":"6","key":"6110_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/ahg.12599","volume":"89","author":"L Zhang","year":"2025","unstructured":"Zhang L, Li Y, Fan W, Xue H (2025) Exploring the causal link between systemic lupus erythematosus and stroke risk through Mendelian randomization study. Ann Hum Genet 89(6):407\u2013414. https:\/\/doi.org\/10.1111\/ahg.12599","journal-title":"Ann Hum Genet"},{"key":"6110_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1565379","volume":"16","author":"X Ma","year":"2025","unstructured":"Ma X, Huang L, Yan H (2025) Shared circulating diagnostic biomarkers and molecular mechanisms in ischemic stroke and systemic lupus erythematosus. Front Immunol 16:1565379. https:\/\/doi.org\/10.3389\/fimmu.2025.1565379","journal-title":"Front Immunol"},{"issue":"5","key":"6110_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0961203320908947","volume":"29","author":"P Guraieb-Chah\u00edn","year":"2020","unstructured":"Guraieb-Chah\u00edn P, Cant\u00fa-Brito C, Soto-Mota A, Guerrero-Torres L, Flores-Silva F, Chiquete E, Fragoso-Loyo H, Gonz\u00e1lez-Duarte A, Vald\u00e9s-Ferrer SI (2020) Stroke in systemic lupus erythematosus: epidemiology, mechanism, and long-term outcome. Lupus 29(5):437\u2013445. https:\/\/doi.org\/10.1177\/0961203320908947","journal-title":"Lupus"},{"issue":"5","key":"6110_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/09612033231165151","volume":"32","author":"G El Hasbani","year":"2023","unstructured":"El Hasbani G, Uthman I (2023) Lupus, antiphospholipid syndrome, and stroke: an attempt to crossmatch. Lupus 32(5):593\u2013602. https:\/\/doi.org\/10.1177\/09612033231165151","journal-title":"Lupus"},{"issue":"2","key":"6110_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1183","volume":"12","author":"N Li","year":"2024","unstructured":"Li N, Liu X, Wu P, Liu J, Chen P, Zeng J (2024) Three cases of systemic lupus erythematosus presenting with ischemic stroke as the initial symptom: case reports and literature review. Immun Inflamm Dis 12(2):e1183. https:\/\/doi.org\/10.1002\/iid3.1183","journal-title":"Immun Inflamm Dis"},{"issue":"1","key":"6110_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/MS9.0000000000001502","volume":"86","author":"YMN Habes","year":"2023","unstructured":"Habes YMN, Ahmaro M, Dwikat Y, Jobran AWM, Abunejma FM, Abdulrazzak M (2023) Stroke as an unusual initial presentation of \u201cmalignant\u201d middle cerebral artery infarction involvement in systemic lupus erythematosus. Ann Med Surg 86(1):517\u2013521. https:\/\/doi.org\/10.1097\/MS9.0000000000001502","journal-title":"Ann Med Surg"},{"issue":"4","key":"6110_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3988\/jcn.2020.16.4.605","volume":"16","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Kim YS, Lee JM, Koh SH, Kim HY, Kim C, Lee SH, Jung KH, Kim YD, Kwon HM, Kim BJ, Kim JM, Kim BJ, Heo SH, Chang DI, SKY Investigators (2020) Causes, risk factors, and clinical outcomes of stroke in korean young adults: systemic lupus erythematosus is associated with unfavorable outcomes. J Clin Neurol 16(4):605\u2013611. https:\/\/doi.org\/10.3988\/jcn.2020.16.4.605","journal-title":"J Clin Neurol"},{"issue":"9","key":"6110_CR22","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1080\/09273948.2025.2563170","volume":"33","author":"M Gad El Sayed","year":"2025","unstructured":"Gad El Sayed M, Tsui E, Fouad Y (2025) Retinal vasculitis and stroke risk in patients with systemic lupus erythematosus. Ocul Immunol Inflamm 33(9):2115\u20132120. https:\/\/doi.org\/10.1080\/09273948.2025.2563170","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"6110_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/09612033251322930","volume":"34","author":"GD Silva","year":"2025","unstructured":"Silva GD, Vieira GT, Rimkus CM, Neves Yuki EF, Azevedo RS, Tinone G, Pereira RM, Conforto AB (2025) Distinctive cerebral small vessel disease patterns are associated with ischemic stroke in systemic lupus erythematosus. Lupus 34(4):348\u2013357. https:\/\/doi.org\/10.1177\/09612033251322930","journal-title":"Lupus"},{"issue":"10","key":"6110_CR24","doi-asserted-by":"publisher","first-page":"10180","DOI":"10.21037\/qims-2024-2541","volume":"15","author":"X Bai","year":"2025","unstructured":"Bai X, Jin S, Xu M, Zhang R, Li Y, Song L, Shu Q, Yu D, Liu Q (2025) Intracranial vessel wall MRI in ischemic stroke in systemic lupus erythematosus: radiological characteristics and clinical associations. Quant Imaging Med Surg 15(10):10180\u201310192. https:\/\/doi.org\/10.21037\/qims-2024-2541","journal-title":"Quant Imaging Med Surg"},{"issue":"4","key":"6110_CR25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3899\/jrheum.200664","volume":"48","author":"LK Tsoi","year":"2021","unstructured":"Tsoi LK, Mok CC, Man BL, Fu YP (2021) Imaging pattern and outcome of stroke in patients with systemic lupus erythematosus: a case-control study. J Rheumatol 48(4):533\u2013540. https:\/\/doi.org\/10.3899\/jrheum.200664","journal-title":"J Rheumatol"},{"issue":"6","key":"6110_CR26","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/rheumatology\/kez456","volume":"59","author":"CH Lai","year":"2020","unstructured":"Lai CH, Hsieh CY, Barnado A, Huang LC, Chen SC, Tsai LM, Shyr Y, Li CY (2020) Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study. Rheumatology (Oxford) 59(6):1355\u20131363. https:\/\/doi.org\/10.1093\/rheumatology\/kez456","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"6110_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.70307","volume":"28","author":"JE Chia","year":"2025","unstructured":"Chia JE, Ang SP, Iglesias J, Krittanawong C, Mukherjee D (2025) Clinical characteristics and outcomes of acute ischemic stroke in patients with systemic lupus erythematosus. A Nationwide Cohort Study. Int J Rheum Dis 28(6):e70307. https:\/\/doi.org\/10.1111\/1756-185X.70307","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"6110_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020462","volume":"12","author":"TA Pana","year":"2023","unstructured":"Pana TA, Jesenakova S, Carter B, Hollick R, Mohamed MO, Mamas MA, Myint PK (2023) Sex-specific outcomes of acute stroke in patients with systemic lupus erythematosus: a National Inpatient Sample study. J Clin Med 12(2):462. https:\/\/doi.org\/10.3390\/jcm12020462","journal-title":"J Clin Med"},{"issue":"6","key":"6110_CR29","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s13760-023-02189-y","volume":"123","author":"F Liu","year":"2023","unstructured":"Liu F, Xie Y, Wu C, Liu H, Zhang J, Lian Y, Xie N (2023) A nested case-control study investigating short-term prognosis, clinical and imaging features in acute ischemic stroke patients with systemic lupus erythematosus. Acta Neurol Belg 123(6):2177\u20132184. https:\/\/doi.org\/10.1007\/s13760-023-02189-y","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"6110_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/20565623.2025.2534329","volume":"11","author":"W Hua","year":"2025","unstructured":"Hua W, Wang L, Xu H, Ma H, Zhang Y, Shen H, Zhang X, Xing P, Yang P (2025) Endovascular thrombectomy of acute ischemic stroke patients with systemic lupus erythematosus: two case reports. Future Sci OA 11(1):2534329. https:\/\/doi.org\/10.1080\/20565623.2025.2534329","journal-title":"Future Sci OA"},{"issue":"43","key":"6110_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040203","volume":"103","author":"G Liu","year":"2024","unstructured":"Liu G, Wang Y, Guan H (2024) Successfully intravenous thrombolytic therapy in systemic lupus erythematosus-related ischemic stroke: a case report. Medicine (Baltimore) 103(43):e40203. https:\/\/doi.org\/10.1097\/MD.0000000000040203","journal-title":"Medicine (Baltimore)"},{"issue":"20","key":"6110_CR32","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.2169\/internalmedicine.9228-21","volume":"61","author":"T Kitano","year":"2022","unstructured":"Kitano T, Hirano T, Okazaki S, Itotagawa E, Yagita Y, Morita Y, Watanabe A, Takahashi D, Sakaguchi M, Fujiwara H, Todo K, Sasaki T, Kumanogoh A, Mochizuki H (2022) Heterogeneity of stroke in patients with systemic lupus erythematosus. Intern Med 61(20):3045\u20133052. https:\/\/doi.org\/10.2169\/internalmedicine.9228-21","journal-title":"Intern Med"},{"key":"6110_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.wneu.2020.01.030","volume":"136","author":"E Tsukamoto","year":"2020","unstructured":"Tsukamoto E, Tanei T, Senda J, Kato T, Naito T, Ishii K, Okada K, Hasegawa T (2020) Subarachnoid hemorrhage after ischemic stroke associated with systemic lupus erythematosus and antiphospholipid syndrome. World Neurosurg 136:248\u2013252. https:\/\/doi.org\/10.1016\/j.wneu.2020.01.030","journal-title":"World Neurosurg"},{"key":"6110_CR34","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.20568","volume":"14","author":"L Yang","year":"2026","unstructured":"Yang L, Liu X, Yang G, Wu H, Li X, Xuan J, Dong S (2026) Rheumatoid arthritis and stroke risk: a systematic review and meta-analysis. PeerJ 14:e20568. https:\/\/doi.org\/10.7717\/peerj.20568","journal-title":"PeerJ"},{"key":"6110_CR35","doi-asserted-by":"publisher","DOI":"10.1177\/17474930251377174","author":"A Shin","year":"2025","unstructured":"Shin A, Kang S, Jung J, Cho IY, Han K, Kim S, Kim SY, Shin DW, Kim H (2025) The association between rheumatoid arthritis and stroke risk by serologic status and stroke subtypes. Int J Stroke. https:\/\/doi.org\/10.1177\/17474930251377174","journal-title":"Int J Stroke"},{"issue":"1","key":"6110_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01288-7","volume":"24","author":"OA Al-Ewaidat","year":"2024","unstructured":"Al-Ewaidat OA, Naffaa MM (2024) Stroke risk in rheumatoid arthritis patients: exploring connections and implications for patient care. Clin Exp Med 24(1):30. https:\/\/doi.org\/10.1007\/s10238-023-01288-7","journal-title":"Clin Exp Med"},{"issue":"1","key":"6110_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s41065-025-00386-8","volume":"162","author":"Q Qin","year":"2025","unstructured":"Qin Q, Jiang Y, Fan H, Yuan R, Zhong B, Zhang Y, Zhang Z, Lei X, Cai J, Cheng S (2025) Investigating the shared genetic structure between rheumatoid arthritis and stroke. Hereditas 162(1):23. https:\/\/doi.org\/10.1186\/s41065-025-00386-8","journal-title":"Hereditas"},{"issue":"4","key":"6110_CR38","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s12975-023-01161-5","volume":"15","author":"Y Jia","year":"2024","unstructured":"Jia Y, Zhang K, Shi M, Guo D, Yang P, Bu X, Chen J, Wang A, Xu T, He J, Zhu Z, Zhang Y (2024) Associations of rheumatoid factor, rheumatoid arthritis, and interleukin-6 inhibitor with the prognosis of ischemic stroke: a prospective multicenter cohort study and mendelian randomization analysis. Transl Stroke Res 15(4):750\u2013760. https:\/\/doi.org\/10.1007\/s12975-023-01161-5","journal-title":"Transl Stroke Res"},{"issue":"2","key":"6110_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-024-05781-4","volume":"45","author":"M Ausserwinkler","year":"2025","unstructured":"Ausserwinkler M, Gensluckner S, Frey V, Gostner I, Paulweber B, Trinka E, Langthaler P, Datz C, Iglseder B, Thiel J, Neumann HJ, Flamm M, Aigner E, Wernly B (2025) Cerebrovascular risk in rheumatoid arthritis patients: insights from carotid artery atherosclerosis in the Paracelsus 10,000 study. Rheumatol Int 45(2):33. https:\/\/doi.org\/10.1007\/s00296-024-05781-4","journal-title":"Rheumatol Int"},{"issue":"11","key":"6110_CR40","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1093\/rheumatology\/keae458","volume":"63","author":"AM Kerola","year":"2024","unstructured":"Kerola AM, Ikdahl E, Engebretsen I, Bugge C, Semb AG (2024) Rheumatoid arthritis and the risk of ischaemic stroke after diagnosis of atrial fibrillation: a Norwegian nationwide register study. Rheumatology (Oxford) 63(11):2997\u20133005. https:\/\/doi.org\/10.1093\/rheumatology\/keae458","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"6110_CR41","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2017-211209","volume":"76","author":"Y Meissner","year":"2017","unstructured":"Meissner Y, Richter A, Manger B, Tony HP, Wilden E, Listing J, Zink A, Strangfeld A (2017) Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort. Ann Rheum Dis 76(9):1583\u20131590. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211209","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6110_CR42","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/art.39582","volume":"68","author":"AS Low","year":"2016","unstructured":"Low AS, Lunt M, Mercer LK, Watson KD, Dixon WG, Symmons DP, Hyrich KL (2016) Association between ischemic stroke and tumor necrosis factor inhibitor therapy in patients with rheumatoid arthritis. Arthritis Rheumatol 68(6):1337\u20131345. https:\/\/doi.org\/10.1002\/art.39582","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"6110_CR43","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/acr.23875","volume":"72","author":"S Singh","year":"2020","unstructured":"Singh S, Fumery M, Singh AG, Singh N, Prokop LJ, Dulai PS, Sandborn WJ, Curtis JR (2020) Comparative risk of cardiovascular events with biologic and synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 72(4):561\u2013576. https:\/\/doi.org\/10.1002\/acr.23875","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6110_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152461","volume":"67","author":"A Goldman","year":"2024","unstructured":"Goldman A, Galper BL, Druyan A, Grossman C, Sharif K, Shechtman L, Moshkovits Y, Lahat A, Ben-Zvi I (2024) Adverse cardiovascular events in rheumatoid arthritis patients treated with JAK inhibitors: an analysis of postmarketing spontaneous safety reports. Semin Arthritis Rheum 67:152461. https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152461","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"6110_CR45","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/acr.25233","volume":"76","author":"MR Hoque","year":"2024","unstructured":"Hoque MR, Avi\u00f1a-Zubieta JA, Lacaille D, De Vera MA, Qian Y, McCandless L, Esdaile JM, Xie H (2024) Antimalarial adherence and risk of cardiovascular events in patients with rheumatoid arthritis and systemic lupus erythematosus: a population-based study. Arthritis Care Res (Hoboken) 76(3):426\u2013436. https:\/\/doi.org\/10.1002\/acr.25233","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"6110_CR46","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11940-015-0356-3","volume":"17","author":"N Dhillon","year":"2015","unstructured":"Dhillon N, Liang K (2015) Prevention of stroke in rheumatoid arthritis. Curr Treat Options Neurol 17(7):356. https:\/\/doi.org\/10.1007\/s11940-015-0356-3","journal-title":"Curr Treat Options Neurol"},{"issue":"4","key":"6110_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.70032","volume":"7","author":"M Cutolo","year":"2025","unstructured":"Cutolo M, Vojinovic T, Paolino S, Campitiello R, Smith V (2025) Cerebrovascular involvement in systemic sclerosis. ACR Open Rheumatol 7(4):e70032. https:\/\/doi.org\/10.1002\/acr2.70032","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"6110_CR48","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1038\/s41598-024-57275-9","volume":"14","author":"IW Chen","year":"2024","unstructured":"Chen IW, Wang WT, Lai YC, Lin CM, Liu PH, Wu SZ, Hung KC (2024) Association between systemic sclerosis and risk of cerebrovascular and cardiovascular disease: a meta-analysis. Sci Rep 14(1):6445. https:\/\/doi.org\/10.1038\/s41598-024-57275-9","journal-title":"Sci Rep"},{"issue":"1","key":"6110_CR49","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3899\/jrheum.181311","volume":"47","author":"D Ying","year":"2020","unstructured":"Ying D, Gianfrancesco MA, Trupin L, Yazdany J, Greidinger EL, Schmajuk G (2020) Increased risk of ischemic stroke in systemic sclerosis: a National Cohort Study of US veterans. J Rheumatol 47(1):82\u201388. https:\/\/doi.org\/10.3899\/jrheum.181311","journal-title":"J Rheumatol"},{"issue":"7","key":"6110_CR50","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9155","volume":"12","author":"E Edigin","year":"2020","unstructured":"Edigin E, Eseaton P, Kaul S, Shaka H, Ojemolon PE, Asemota IR, Akuna E, Manadan A (2020) Systemic sclerosis is not associated with worse outcomes of patients admitted for ischemic stroke: analysis of the National Inpatient Sample. Cureus 12(7):e9155. https:\/\/doi.org\/10.7759\/cureus.9155","journal-title":"Cureus"},{"issue":"3","key":"6110_CR51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.reumae.2023.02.002","volume":"19","author":"AS Bhagavathula","year":"2023","unstructured":"Bhagavathula AS, Bentley BL, Woolf B, Dissanayaka TD, Rahmani J (2023) Increased risk of stroke among patients with ankylosing spondylitis: A systematic review and meta-analysis. Reumatol Clin (Engl Ed) 19(3):136\u2013142. https:\/\/doi.org\/10.1016\/j.reumae.2023.02.002","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"2","key":"6110_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5152\/eurasianjmed.2024.23330","volume":"56","author":"MM Heidari","year":"2024","unstructured":"Heidari MM, Khaledi A, Taravati AM, Rastegar-Kashkouli A, Moammer F, Safari I (2024) Relationship between ankylosing spondylitis and cerebrovascular disorders: a systematic review. Eurasian J Med 56(2):127\u2013135. https:\/\/doi.org\/10.5152\/eurasianjmed.2024.23330","journal-title":"Eurasian J Med"},{"issue":"4","key":"6110_CR53","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/1756-185X.13970","volume":"24","author":"JH Kim","year":"2021","unstructured":"Kim JH, Choi IA (2021) Cardiovascular morbidity and mortality in patients with spondyloarthritis: a meta-analysis. Int J Rheum Dis 24(4):477\u2013486. https:\/\/doi.org\/10.1111\/1756-185X.13970","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"6110_CR54","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000514889","volume":"55","author":"K Tr\u00f6mmer","year":"2021","unstructured":"Tr\u00f6mmer K, Kostev K, Jacob L, Tanislav C (2021) Increased incidence of stroke and transient ischemic attack in patients with rheumatoid arthritis and ankylosing spondylitis in Germany. Neuroepidemiology 55(2):162\u2013170. https:\/\/doi.org\/10.1159\/000514889","journal-title":"Neuroepidemiology"},{"issue":"13","key":"6110_CR55","doi-asserted-by":"publisher","first-page":"1095622","DOI":"10.3389\/fimmu.2022.1095622","volume":"19","author":"J Mei","year":"2023","unstructured":"Mei J, Wei P, Zhang L, Ding H, Zhang W, Tang Y, Fang X (2023) Impact of ankylosing spondylitis on stroke limited to specific subtypes: Evidence from Mendelian randomization study. Front Immunol 19(13):1095622. https:\/\/doi.org\/10.3389\/fimmu.2022.1095622","journal-title":"Front Immunol"},{"issue":"6","key":"6110_CR56","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1007\/s00415-024-12251-1","volume":"271","author":"R Geraldes","year":"2024","unstructured":"Geraldes R, Santos M, Ponte C, Craven A, Barra L, Robson JC, Hammam N, Springer J, Henes J, Hocevar A, Putaala J, Santos E, Rajasekhar L, Daikeler T, Karadag O, Costa A, Khalidi N, Pagnoux C, Canh\u00e3o P, Melo TPE, Fonseca AC, Ferro JM, Fonseca JE, Suppiah R, Watts RA, Grayson P, Merkel PA, Luqmani RA, DCVAS Study Group (2024) Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study. J Neurol 271(6):3309\u20133320. https:\/\/doi.org\/10.1007\/s00415-024-12251-1","journal-title":"J Neurol"},{"issue":"8","key":"6110_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13778","volume":"52","author":"KW Chuang","year":"2022","unstructured":"Chuang KW, Chang HC (2022) Risk of ischaemic heart diseases and stroke in Beh\u00e7et disease: a systematic review and meta-analysis. Eur J Clin Invest 52(8):e13778. https:\/\/doi.org\/10.1111\/eci.13778","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"6110_CR58","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3899\/jrheum.190408","volume":"47","author":"HS Ahn","year":"2020","unstructured":"Ahn HS, Lee D, Lee SY, Kim YH, Lee JH, Yu DS, Han KD, Park YG, Lee YB (2020) Increased cardiovascular risk and all-cause death in patients with Beh\u00e7et disease: a Korean nationwide population-based dynamic cohort study. J Rheumatol 47(6):903\u2013908. https:\/\/doi.org\/10.3899\/jrheum.190408","journal-title":"J Rheumatol"},{"issue":"6","key":"6110_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218652","volume":"14","author":"CY Wu","year":"2019","unstructured":"Wu CY, Yu HS, Chai CY, Wen YH, Wu SS, Chang YP, Lin CR, Tsai JH (2019) Increased ischemic stroke risk in patients with Beh\u00e7et\u2019s disease: a nationwide population-based cohort study. PLoS ONE 14(6):e0218652. https:\/\/doi.org\/10.1371\/journal.pone.0218652","journal-title":"PLoS ONE"},{"key":"6110_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01102","volume":"10","author":"H Yin","year":"2019","unstructured":"Yin H, Song Y, Zheng M, Han J, Tang J (2019) Beh\u00e7et\u2019s disease with cerebral artery infarction caused by cerebral arteritis as an early symptom only with elevated Interleukin-8. Front Neurol 10:1102. https:\/\/doi.org\/10.3389\/fneur.2019.01102","journal-title":"Front Neurol"},{"key":"6110_CR61","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jns.2019.01.044","volume":"398","author":"N Hamza","year":"2019","unstructured":"Hamza N, Ben Sassi S, Nabli F, Nagi S, Mahmoud M, Ben Abdelaziz I, Hentati F (2019) Stroke revealing Neuro-Beh\u00e7et\u2019s disease with parenchymal and extensive vascular involvement. J Neurol Sci 398:131\u2013134. https:\/\/doi.org\/10.1016\/j.jns.2019.01.044","journal-title":"J Neurol Sci"},{"issue":"11","key":"6110_CR62","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49222","volume":"15","author":"S Khafaji","year":"2023","unstructured":"Khafaji S, Alzahrani MS, Muddassir R, Almuhanna RA (2023) Recurrent stroke as a first presentation in Beh\u00e7et disease: a case report. Cureus 15(11):e49222. https:\/\/doi.org\/10.7759\/cureus.49222","journal-title":"Cureus"},{"issue":"1","key":"6110_CR63","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000545635","volume":"16","author":"S Jabbehdari","year":"2025","unstructured":"Jabbehdari S, Oganov A, Uwaydat SH (2025) From retinal vasculitis to stroke, from systemic findings to diagnosis, the necessity of multidisciplinary management in Beh\u00e7et\u2019s Disease: a case report. Case Rep Ophthalmol 16(1):317\u2013322. https:\/\/doi.org\/10.1159\/000545635","journal-title":"Case Rep Ophthalmol"},{"issue":"5","key":"6110_CR64","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.4103\/0028-3886.359250","volume":"70","author":"P Ungprasert","year":"2022","unstructured":"Ungprasert P, Wijarnpreecha K, Dejhansathit S, Cheungpasitporn W (2022) Antineutrophil cytoplasmic autoantibodies-associated vasculitides and risk of stroke: a systematic review and meta-analysis. Neurol India 70(5):1868\u20131873. https:\/\/doi.org\/10.4103\/0028-3886.359250","journal-title":"Neurol India"},{"issue":"8","key":"6110_CR65","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1093\/rheumatology\/keac669","volume":"62","author":"D Tabakovic","year":"2023","unstructured":"Tabakovic D, Smith R, Jayne D, Mohammad AJ (2023) High risk of stroke in ANCA-associated vasculitis-a population-based study. Rheumatology (Oxford) 62(8):2806\u20132812. https:\/\/doi.org\/10.1093\/rheumatology\/keac669","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"6110_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2022.105498","volume":"90","author":"JK Ahn","year":"2023","unstructured":"Ahn JK, Hwang J, Choi CB, Seo GH (2023) Risk of acute myocardial infarction, stroke, and venous thromboembolism among patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in South Korea: a nationwide population-based study. Joint Bone Spine 90(2):105498. https:\/\/doi.org\/10.1016\/j.jbspin.2022.105498","journal-title":"Joint Bone Spine"},{"key":"6110_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.629902","volume":"12","author":"SS Ahn","year":"2021","unstructured":"Ahn SS, Han M, Yoo J, Park YB, Jung I, Lee SW (2021) Risk of stroke in systemic necrotizing vasculitis: a nationwide study using the National Claims Database. Front Immunol 12:629902. https:\/\/doi.org\/10.3389\/fimmu.2021.629902","journal-title":"Front Immunol"},{"key":"6110_CR68","unstructured":"Beir\u00e3o T, Coelho C, Ferreira N, Rodrigues M, Videira T, Pimenta J. Concomitant ischemic stroke and myocarditis as the initial clinical presentation of Takayasu arteritis. ARP Rheumatol. 2022. English. Epub ahead of print."},{"issue":"13","key":"6110_CR69","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1080\/14656566.2020.1770227","volume":"21","author":"P Piranavan","year":"2020","unstructured":"Piranavan P, Perl A (2020) Management of cardiovascular disease in patients with systemic lupus erythematosus. Expert Opin Pharmacother 21(13):1617\u20131628. https:\/\/doi.org\/10.1080\/14656566.2020.1770227","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"6110_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.101724","volume":"4","author":"AC Razavi","year":"2025","unstructured":"Razavi AC, Troy AL, Patel J, Mehta LS, Spitz JA, Lloyd-Jones D, Whelton SP, Johansen MC, Blumenthal RS (2025) Future of stroke prevention: 7 updates in the 2024 AHA\/ASA primary prevention of stroke guideline. JACC Adv 4(6):101724. https:\/\/doi.org\/10.1016\/j.jacadv.2025.101724","journal-title":"JACC Adv"},{"issue":"3","key":"6110_CR71","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1161\/STROKEAHA.119.024157","volume":"51","author":"NS Parikh","year":"2020","unstructured":"Parikh NS, Merkler AE, Iadecola C (2020) Inflammation, autoimmunity, infection, and stroke: epidemiology and lessons from therapeutic intervention. Stroke 51(3):711\u2013718. https:\/\/doi.org\/10.1161\/STROKEAHA.119.024157","journal-title":"Stroke"},{"issue":"8","key":"6110_CR72","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1111\/1756-185X.13611","volume":"22","author":"CH Tang","year":"2019","unstructured":"Tang CH, Yu F, Huang CY, Chen DY (2019) Potential benefits of biologics on stroke and mortality in patients with rheumatoid arthritis: a nationwide population-based cohort study in Taiwan. Int J Rheum Dis 22(8):1544\u20131552. https:\/\/doi.org\/10.1111\/1756-185X.13611","journal-title":"Int J Rheum Dis"},{"key":"6110_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2022.107199","volume":"215","author":"M Fana","year":"2022","unstructured":"Fana M, Chao S, Katramados AM (2022) Rituximab for prevention of strokes in cerebral rheumatoid vasculitis. Clin Neurol Neurosurg 215:107199. https:\/\/doi.org\/10.1016\/j.clineuro.2022.107199","journal-title":"Clin Neurol Neurosurg"},{"key":"6110_CR74","doi-asserted-by":"publisher","first-page":"119","DOI":"10.55563\/clinexprheumatol\/6spy2c","volume":"39","author":"A Mendel","year":"2021","unstructured":"Mendel A, Ennis D, Carette S, Pagnoux C (2021) Assessment of glucocorticoid tapering in large vessel and anti-neutrophil cytoplasmic antibody-associated vasculitides. Clin Exp Rheumatol 39:119\u2013124. https:\/\/doi.org\/10.55563\/clinexprheumatol\/6spy2c","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"6110_CR75","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/art.23816","volume":"59","author":"TU Nguyen-Oghalai","year":"2008","unstructured":"Nguyen-Oghalai TU, Wu H, McNearney TA, Granger CV, Ottenbacher KJ (2008) Functional outcome after stroke in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 59(7):984\u2013988. https:\/\/doi.org\/10.1002\/art.23816","journal-title":"Arthritis Rheum"},{"issue":"11","key":"6110_CR76","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3899\/jrheum.170241","volume":"44","author":"M Rossides","year":"2017","unstructured":"Rossides M, Simard JF, Svenungsson E, von Euler M, Arkema EV (2017) Mortality and functionality after stroke in patients with systemic lupus erythematosus. J Rheumatol 44(11):1590\u20131596. https:\/\/doi.org\/10.3899\/jrheum.170241","journal-title":"J Rheumatol"},{"issue":"10","key":"6110_CR77","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/STROKEAHA.121.034270","volume":"52","author":"J Fournier","year":"2021","unstructured":"Fournier J, Finestone H, Lauzon J, Campbell TM (2021) Prevalence, impact, and treatment of co-occurring osteoarthritis in patients with stroke undergoing rehabilitation: a review. Stroke 52(10):e618\u2013e621. https:\/\/doi.org\/10.1161\/STROKEAHA.121.034270","journal-title":"Stroke"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06110-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06110-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06110-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:30:00Z","timestamp":1781645400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06110-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":77,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6110"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06110-7","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"75"}}